Pyxis Oncology (PYXS) Interest Coverage Ratio (2020 - 2025)
Pyxis Oncology's (PYXS) quarterly Interest Coverage Ratio came in at 7.59 in Q4 2025, up 116.96% year-on-year from 3.5 in Q4 2024, and up 299.53% on a QoQ basis from 3.81 in Q3 2025.
Pyxis Oncology (PYXS) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 6 years of Interest Coverage Ratio data on file, last reported at 7.59 in Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 116.96% year-over-year to 7.59 in Q4 2025; TTM through Dec 2025 was 981.63, a 1681.18% decrease from a year earlier, with the FY2025 full-year figure at 3.27, down 413.61% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 7.59, up from 3.81 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for PYXS reached as high as 59.61 in Q4 2022 and fell as low as 224.37 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 19.83 across 5 years, with a median of 3.89 in 2023.
- Across the five-year window, Interest Coverage Ratio surged 6056.87% in 2022 and plunged 10261.57% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 1.0 in 2021, then soared by 6056.87% to 59.61 in 2022, then slumped by 82.46% to 10.46 in 2023, then slumped by 528.12% to 44.77 in 2024, then jumped by 116.96% to 7.59 in 2025.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 7.59 in Q4 2025, 3.81 in Q3 2025, and 24.69 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Pyxis Oncology | 166.54 Mn | 99.69 Mn | 8.65 Mn | 7.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.59 |
| Sep 30, 2025 | -3.81 |
| Jun 30, 2025 | -24.69 |
| Mar 31, 2025 | -28.64 |
| Dec 31, 2024 | -44.77 |
| Sep 30, 2024 | -4.51 |
| Jun 30, 2024 | -4.97 |
| Mar 31, 2024 | -0.73 |
| Dec 31, 2023 | 10.46 |
| Sep 30, 2023 | -224.37 |
| Jun 30, 2023 | -17.41 |
| Mar 31, 2023 | -3.97 |
| Dec 31, 2022 | 59.61 |
| Sep 30, 2022 | -2.17 |
| Jun 30, 2022 | -1.91 |
| Mar 31, 2022 | -71.34 |
| Dec 31, 2021 | -1.00 |
| Sep 30, 2021 | -0.33 |
| Dec 31, 2020 | -1.05 |